PROGRAM. Embassy Suites Hotel Kennesaw Town Center
|
|
|
- Irene Lucas
- 5 years ago
- Views:
Transcription
1 Thursday, March 5, :30 21:30 Welcome Reception Ballroom Salons A and B Friday, March 6, :00 7:00 Breakfast Breakfast Area 7:00 Transportation Buses to CryoLife Headquarters, Kennesaw, GA 7:30 18:40 Didactic Sessions Elkins Learning Center 7:30 7:45 Welcome Pat Mackin, CEO CryoLife William Northrup 7:45 8:45 Session I. The Moving Target of Evolving Dialysis Access Algorithms: Catheters, Fistulas and Grafts Another look at fistulas. Charmaine Lok The changing paradigm with graft creation. Eric Chemla The Kidney Health Initiative: Potential impact on access algorithms. 8:45 9:45 Session II. Scope and Cause of Central Venous Pathology Anatomy and classification of central vein occlusion Creating a new nomenclature. What we ve learned about intimal hyperplasia the Achilles Heel of dialysis access. Surendra Shenoy
2 8:45 9:45 Session II. Scope and Cause of Central Venous Pathology (continued) Central venous pathology: etiology, prevalence and prevention. Eric Chemla 9:45 10:05 Session III. Imaging Requirements for Central Venous Pathology 10:05 10:20 Break What imaging techniques are required to adequately define the extent of central venous pathology? Charles Kim HeRO simulation, femoral allograft and ProCol Vascular Prosthesis demonstrations in Atrium and CryoCafe 10:20 11:20 Session IV. Specific Algorithms to Prevent Central Venous Pathology During Common Clinical Situations Algorithms by a nephrologist to avoid central venous catheters in acute and chronic renal failure patients. Charmaine Lok An interventional nephrologist s approach to preventing central venous pathology. Access Teams: Do they reduce tunneled dialysis catheter exposure? Aris Urbanes 11:20 12:40 Session V. Management of Central Venous Pathology Tips and tricks: Central venous recanalization. Charles Kim
3 11:20 12:40 Session V. Management of Central Venous Pathology (continued) 12:40 12:55 Group Photo 12:55 13:25 Lunch Are central venous stents effective after failed angioplasty? The data. Dirk Hentschel A safe, simple and effective technique to cross a central venous occlusion: the Alien. Algorithms of access placement in the complex ESRD patient with central venous pathology. (Presentation: 5 min each, Discussion: 5 min each) Aris Urbanes: Nephrologist Eric Peden: Surgeon 13:25 14:45 Session VI. The HeRO Graft Clinical data update on the HeRO Graft. ` Implementing the HeRO Graft: Perspectives from transplant surgeons. (Presentation: 5 min each, Discussion: 5 min each) Christie Gooden George Blessios Mistakes to avoid with HeRO Graft placement: accelerating the learning curve for the early adopter. Impact of an early cannulation graft with the HeRO Graft/New Adapter. 14:45 15:25 Session VII. Saving central veins: Role of the HeRO Graft Experience with the HeRO Graft outflow to save fistulas and grafts with compromised downstream flow the concept of a replaceable stent. Jeffrey Lawson
4 14:45 15:25 Session VII. Saving central veins: Role of the HeRO Graft (continued) Avoiding HeRO Graft abandonment: Algorithm for graft salvage. 15:25 16:05 Session VIII. Remedies for thoracic outlet ( inlet ) venous obstruction 16:05 16:20 Break Remedies for cephalic arch obstruction. (Presentation: 5 min each, Discussion: 5 min each) Surendra Shenoy Surgery Dirk Hentschel Interventional Nephrology Claviculectomy versus first rib resection. Eric Peden HeRO simulation, femoral allograft and ProCol Vascular Prosthesis demonstrations in Atrium and CryoCafe 16:20 17:00 Session IX. The HeRO Graft and dialysis access guidelines Does the HeRO Graft fit within any future U.S. Guidelines? Does the HeRO Graft fit within any future European Guidelines? Eric Chemla 17:00 17:40 Session X. Tissue graft solutions for challenged dialysis patients Bovine mesenteric vein grafts (ProCol Vascular Prosthesis) for failed access grafts. Jeffrey Lawson Femoral venous allografts for the complex arteriovenous access. James Kohn
5 17:40 18:40 Session XI. Emerging and Underutilized Technology What s NEAT: Current status of endovascular fistula formation. William Cohn New HeRO Graft Adapter: Availability status, utility and future directions. Baylis Medical Company, RF Powerwire: Indications and experience. (Presentation: 5min, Discussion: 3 min) Charles Kim Bioconnect Optiflow Anastomotic Connector: Recent clinical experience. Adam Dakin Humacyte: Clinical experience with a biological vascular graft. Jeffrey Lawson Drug-Eluting Balloon: Current clinical experience. TBD Phraxis: A percutaneous AV shunt for dialysis access. Alexander Yevzlin InnAVasc Medical: An immediate cannulation graft that prevents back wall and various cannulation injuries. Shawn Gage 18:40 Transportation Buses to Hotel 19:30 22:00 Cocktails, Hors d oeuvres, Dinner Ballroom Salons A and B
6 Saturday, March 7, :00 7:00 Breakfast Breakfast Area 7:00 Transportation Buses to CryoLife All Attendees : 7:30 8:30 Didactic Sessions Elkins Learning Center 7:30 8:00 Session I: Central Venous Anatomy Cadaver Lab Moderator in the auditorium: Demonstration in a perfused human cadaver William Northrup 8:00 8:30 Session II: HeRO Graft Implant Technique Cadaver Lab Moderator in the auditorium: 8:30 8:45 Break Surgeons: Demonstration with the polycarbonate HeRO Simulator and cadaver. William Northrup HeRO simulation, femoral allograft and ProCol demonstrations in Atrium and CryoCafe 8:45 11:45 Hands-On Sessions Cadaver Lab 8:45 10:15 Session I: HeRO Graft Implantation in 3 Human Cadavers Shawn Gage
7 Saturday, March 7, 2015 (continued) 8:45 11:45 Hands-On Sessions (continued) 10:15 11:00 Session II: Femoral Vein Allograft Implantation Technique in a Human Cadaver James Kohn 11:00 11:45 Session III: ProCol Vascular Prosthesis Implantation Technique in a Human Cadaver Shawn Gage 11:45 12:15 Session IV: Final Debriefing, Questions and Answers: Adoption Barriers, Next Steps Auditorium Faculty Nurses and Technicians: 8:45 11:45 Didactic Session 11:45 12:15 Break All Attendees and Faculty: 12:15 13:00 Lunch CryoCafe Types of Hemodialysis Access: Order of Preference (2 CE Credits). Yacoub Room Presenter: Donna Syracuse HeRO simulation, femoral allograft and ProCol demonstrations in Atrium and CryoCafe 13:00 Transportation Buses to airport
PROGRAM. September 27-28, 2013 Westin Cincinnati CINCINNATI HEMODIALYSIS VASCULAR ACCESS SYMPOSIUM 2013
Sponsored by the University of Cincinnati Departments of Surgery and Medicine in partnership with The Renal Network Symposium Chairmen: Rino Munda, MD Prabir Roy-Chaudhury, MD, PhD PROGRAM CINCINNATI HEMODIALYSIS
The HeRO Graft. Shawn M. Gage, PA Division of Vascular Surgery Duke University Medical Center
The HeRO Graft Shawn M. Gage, PA Division of Vascular Surgery Duke University Medical Center Faculty Disclosure I disclose the following financial relationships: CryoLife/Hemosphere, Inc. & W.L. Gore and
AV Access Technology and Innovation DEVICES CHANGING HOW WE THINK ABOUT VASCULAR ACCESS
AV Access Technology and Innovation DEVICES CHANGING HOW WE THINK ABOUT VASCULAR ACCESS Vascular Access New Technology What problem are you trying to solve for? Most common problem is inadequate outflow
HeRO. Jeffrey H. Lawson, M.D., Ph.D. Departments of Surgery and Pathology Duke University Medical Center Durham, North Carolina
HeRO Jeffrey H. Lawson, M.D., Ph.D. Departments of Surgery and Pathology Duke University Medical Center Durham, North Carolina Disclosures Consulting, Clinical Trials and Opinion Hemosphere Ark Therapeutics
Introduction to the Native Arteriovenous Fistula: A primer for medical students and radiology residents
Introduction to the Native Arteriovenous Fistula: A primer for medical students and radiology residents Jesus Contreras, D.O. PGY-4 John Yasmer, D.O. Department of Radiology No Disclosures Objectives Introduce
UC SF. End Stage Renal Disease. National Kidney Foundation Dialysis Outcomes Quality Initiative (K/DOQI) BUT-- No Cephalic Vein What s Next
No Cephalic Vein What s Next End Stage Renal Disease Charles Eichler MD Clinical Professor of Surgery Division of Vascular Surgery UCSF April 5, 2014 Population of patients with ESRD growing rapidly -
Prospective, randomized controlled study of paclitaxel-coated versus plain balloon angioplasty for the treatment of failing dialysis access
Prospective, randomized controlled study of paclitaxel-coated versus plain balloon angioplasty for the treatment of failing dialysis access Disclosure Speaker name:... I have the following potential conflicts
The Role of LUTONIX 035 DCB in AV Fistula Dysfunction Management in our Practice
The Role of LUTONIX 035 DCB in AV Fistula Dysfunction Management in our Practice Dr Kate Steiner Consultant Interventional Radiologist East and North Hertfordshire NHS Trust Disclosure Speaker name: Dr
ASDIN 9th Annual Scientific Meeting
Stent Graft Placement is Best for Cephalic Arch and Central Vein Stenosis Dheeraj K. Rajan MD, FRCPC, FSIR Head - Division of Vascular and Interventional Radiology University of Toronto University Health
Mayo Clinic Course on Shoulder Tendon Transfers & Complex Rotator Cuff Repair Program Schedule
Mayo Clinic Course on Shoulder Tendon Transfers & Complex Rotator Cuff Repair Program Schedule Thursday, April 27, 2017 6:30 a.m. Registration and Continental Breakfast 6:50 a.m. Welcome and Announcements
What s on the Horizon in Dialysis Access? Libby Watch, MD, FACS Miami Cardiac & Vascular Institute
What s on the Horizon in Dialysis Access? Libby Watch, MD, FACS Miami Cardiac & Vascular Institute Disclosures No relevant disclosures Employee Advanced Access Care Dialysis Work 5 operating surgeons 3
4/29/2012. Management of Central Vein Stenoses. Central Venous Stenoses and Occlusions
Central Venous Stenoses and Occlusions Management of Central Vein Stenoses Robert K. Kerlan Jr. M.D. Professor of Clinical Radiology and Surgery University of California San Francisco Key Questions What
Jimmy Wei Hwa Tan, Surg, MD
Jimmy Wei Hwa Tan, Surg, MD Director, Department of Surgery Chief, Department of Cardiovascular Surgery Tainan An-Nan Municipal Hospital, China Medical University, Taiwan Disclosure I have the following
Regardless of whether you are a vascular surgeon,
C A S E R E P O R T The Versatility of the GORE VIABAHN Endoprosthesis Several case reports highlighting its unique design and why it is a valuable tool for the interventionist. BY PETER WAYNE, MD Regardless
FINAL OUTCOMES REPORT
OVERVIEW FINAL OUTCOMES REPORT The annual Endovascular Advances: A Hands On Preceptorship Program is a continuing medical education series designed to provide physicians with hands on training in all aspects
Lutonix AV Clinical Trial
Long Term Effects of LUTONIX 035 DCB Catheter Interim 24 Month Results Ta-Wei Su MD Vascular surgery CGMH Taiwan Disclosure I have the following potential conflicts of interest to report: Consulting Employment
IN ARTERIOVENOUS FISTULA FAILURE
DRUG ELUTING BALLOON ANGIOPLASTY IN ARTERIOVENOUS FISTULA FAILURE Nicola Troisi, MD GUIDELINES GUIDELINES VAS 2007 GUIDELINES VAS 2007 GUIDELINES VAS 2007 GUIDELINES VAS 2007 2007!!!!!!!!!! GUIDELINES
Thoracic Central Venous Obstruction (T-CVO) A New Look at an Old Problem. (This is what we say about T-CVO!)
Thoracic Central Venous Obstruction (T-CVO) These are ALL examples of T-CVO Paget- Schroetter Syndrome A New Look at an Old Problem Bart Dolmatch, MD, FSIR but each one is a different Cellulitis in swollen
Lutonix AV Clinical Trial
Long Term Effects of LUTONIX 035 DCB Catheter Interim 24 Month Results Scott O. Trerotola, MD, for the Lutonix AV Investigators Stanley Baum Professor of Radiology Professor of Radiology in Surgery Associate
Preservation of Veins and Timing for Vascular Access
Preservation of Veins and Timing for Vascular Access Vassilis Liakopoulos, MD, PhD Department of Nephrology School of Medicine University of Thessaly Greece Hemodialysis VA A sound long-term dialysis access
Pitfalls in pushing fistulas ----
Pitfalls in pushing fistulas ---- An argument for more grafts Marc Webb, MD, FACS Michigan Vascular Access, PC March 27 th, 2009 Vascular Access for Hemodialysis ------- Basic facts - the need for Access
Renal Physicians Association Kidney Quality Improvement Registry, Powered by Premier, Inc non-mips Measure Specifications
Renal Physicians Association Kidney Quality Improvement Registry, Powered by Premier, Inc. 2018 non-mips Measure Specifications Last updated January 2, 2018 RPAQIR1: Angiotensin Converting Enzyme (ACE)
HD Scanning: Velocities and Volume Flow
HD Scanning: Velocities and Volume Flow Non-Invasive Lab Symposium West Orange, NJ April 27, 2018 Volume Flow Cindy Sturt, MD, FACS, RVT 500,000 Americans on dialysis 20-25% annual mortality 65% 5 year
AV ACESS COMPLICATIONS. Ass. Prof. Dr. Habas
AV ACESS COMPLICATIONS Ass. Prof. Dr. Habas COMPLICATION AVF IS CONSIDERED A MINOR PROCEDURE INCIDENCE OF COMPLICATION- 20-27% MANY A COMPLICATION LEADS TO FAILURE OF FISTULA LOSS OF SITE AND VEIN FOR
Thrombectomy, open, arteriovenous fistula without revision, autogenous or nonautogenous dialysis graft (separate procedure)
Dialysis Vascular Access Coverage, Coding and Reimbursement Overview Hospital Outpatient 2019 Edition All Reimbursement Amounts are Listed at ational Unadjusted Medicare Rates and Do ot Include the 2%
Gerald Beathard Annual State of the Art Lecture Innovations in Vascular Access - Have We Moved Forward?
Gerald Beathard Annual State of the Art Lecture Innovations in Vascular Access - Have We Moved Forward? Maurizio Gallieni Nephrology and Dialysis Unit Ospedale S. Carlo Borromeo, ASST Santi Paolo e Carlo,
ASDIN 8th Annual Scientific Meeting
Fistula First Breakthrough Initiative Fistula First Breakthrough Initiative Marianne Neumann, RN, CNN FFBI Clinical Lead New Orleans, LA February 26, 2012 Initiated in 2003 by CMS, Goals Include: to ensure
Vascular Access for Patients affected by non Renal Disorders. Eric S Chemla St George s vascular Institute London UK
Vascular Access for Patients affected by non Renal Disorders Eric S Chemla St George s vascular Institute London UK Disclosures Gore Covidien Maquet Proteon Therapeutics INTRODUCTION I First fistula in
Cardiovascular Implantable Electronic Device Leads & Arteriovenous Hemodialysis Access
Cardiovascular Implantable Electronic Device Leads & Arteriovenous Hemodialysis Access Theodore F. Saad, MD Nephrology Associates, PA Christiana Care Health System Newark, Delaware Cardiovascular Implantable
First experience with DCB for treatment of dialysis access stenosis The Greek experience
First experience with DCB for treatment of dialysis access stenosis The Greek experience D Karnabatidis Department of Interventional Radiology Patras University Hospital Patras, Greece Background Vessel
Supera for the Juxta-anastomotic AVF Stenosis
Supera for the Juxta-anastomotic AVF Stenosis Dr Shannon D. Thomas Vascular Access Surgeon Conjoint Senior Lecturer University of New South Wales Sydney, Australia Disclosure Speaker name: Dr S. D. Thomas...
2/18/2015 ASDIN SIMULATION AND TRAINING IN DIALYSIS ACCESS HUMAN FACTORS AND PATIENTS SAFETY
SIMULATION AND TRAINING IN DIALYSIS ACCESS HUMAN FACTORS AND PATIENTS SAFETY ASDIN 11 TH ANNUAL MEETING ORLANDO, FEBRUARY 15, 2015 INGEMAR DAVIDSON DALLAS, TEXAS M.K. Widmer, I. Davidson. Simulation training
Lutonix in AV fistula and Early look AV IDE trial data
Lutonix in AV fistula and Early look AV IDE trial data Jackie P Ho Dept of Cardiac, Thoracic & Vascular Surgery National University of Singapore NUHS, Singapore Lutonix in AV fistula and final AV IDE trial
Case #1. Case #1- Possible codes. Unraveling the -59 modifier. Principles of Interventional. CASE 1: Simple angioplasty
Unraveling the -59 modifier Principles of Interventional Coding Donald Schon, MD, FACP Debra Lawson, CPC, PCS Distinct or independent from other services performed on the same day Normally not reported
Novel solutions for access challenges
Novel solutions for access challenges Mr James Gilbert Consultant Transplant & Vascular Access Surgeon Disclosures I have the following potential conflicts of interest to report: I currently hold a consultancy
Morbidity Audit and Logbook Tool SNOMED Board Reporting Terms for SET and IMG Vascular Surgery AMPUTATION AORTA
SNOMED s for SET and IMG Vascular Surgery AMPUTATION Amputation above-knee Amputation of leg through tibia and fibula Amputation of the foot Amputation of toe Through knee amputation Ray amputation of
Percutaneous transluminal angioplasty in the treatment of stenosis of hemodialysis arteriovenous fistulae: our experience
Percutaneous transluminal angioplasty in the treatment of stenosis of hemodialysis arteriovenous fistulae: our experience Poster No.: C-3355 Congress: ECR 2010 Type: Scientific Exhibit Topic: Interventional
Surgical Options in Thrombectomy for Non-Surgeons
Surgical Options in Thrombectomy for Non-Surgeons Shouwen Wang, MD, PhD, FASDIN AKDHC Ambulatory Surgery Center Arizona Kidney Disease and Hypertension Center Phoenix, Arizona Disclosure No relevant financial
LLUSD & AAID Implant Dentistry MaxiCourse 2018 Co-Directors: Jaime L. Lozada, DDS Coordinator, Mathew Kattadiyil, DDS, MDS, MS March 8-9, 2018
LLUSD & AAID Implant Dentistry MaxiCourse 2018 Co-Directors: Jaime L. Lozada, DDS Coordinator, March 8-9, 2018 LOCATION SPEAKERS TOPICS March 8 th Thursday 4th floor Room 4220 A 7:15 am 8:15 am Registration/Pictures
All arteriovenous access circuits, whether native vein
Summary of the Gore REVISE Clinical Study This nationwide study reports on the safety and effectiveness of the GORE VIHN Endoprosthesis for the treatment of stenoses and thrombotic occlusions involving
JVA ISSN Hemodialysis vascular access management in the Netherlands. Introduction ORIGINAL ARTICLE
JVA ISSN 1129-7298 J Vasc Access 2015; 16 (Suppl 9): S11-S15 DOI: 10.5301/jva.5000366 ORIGINAL ARTICLE Hemodialysis vascular access management in the Netherlands Jan H.M. Tordoir 1, Magda M. van Loon 1,
4 th International Aortic Summit October, 11-13, 2017 Hilton Aruba Hotel SCIENTIFIC PRELIMINARY PROGRAM
4 th International Aortic Summit October, 11-13, 2017 Hilton Aruba Hotel SCIENTIFIC PRELIMINARY PROGRAM WEDNESDAY, OCTOBER 11, 2017 10:00 AM ARRIVALS & REGISTRATION 12:00PM WELCOME Joseph V. Lombardi &
Disclosures. Consultant/Independent Contractor: B Braun, Teleflex, MedComp, Cook, Bard, WL Gore Royalty: Cook, Teleflex
Disclosures Consultant/Independent Contractor: B Braun, Teleflex, MedComp, Cook, Bard, WL Gore Royalty: Cook, Teleflex DCB in Hemodialysis Access Scott Trerotola, MD 2016: 50 th birthday of the AVF History
Surgical Privileges Form: Vascular Surgery
Surgical Form: Vascular Surgery Clinical Request Applicant s Name:. License No. (If Any):... Date:... Scope of Practice:. Facility:.. Place of Work:. CATEGORY I: GENERAL PRIVILEGES 1. Admitting privileges
Why Can't I Cannulate This Fistula? Fistula Immaturity: The Simple But Critical Steps for a Functioning (Mature) AVF
Why Can t I Cannulate This Access? Steven J. Bander M.D. Adjunct Professor of Nephrology St. Louis University Director, Vascular Access Center, St. Luke s Hospital Saint Louis, MO Why Can't I Cannulate
LLUSD & AAID Implant Dentistry MaxiCourse 2018 Co-Directors: Jaime L. Lozada, DDS Coordinator, Mathew Kattadiyil, DDS, MDS, MS March 8-9, 2018
LLUSD & AAID Implant Dentistry MaxiCourse 2018 Co-Directors: Jaime L. Lozada, DDS Coordinator, March 8-9, 2018 LOCATION SPEAKERS TOPICS March 8 th Thursday 4th floor Room 4220 A 7:15 am 8:15 am Registration/Pictures
Delineation Of Privileges Vascular Surgery Privileges
CATEGORY 1 - VASCULAR SURGERY PRIVILEGES Criteria: New Applicants must meet one of the following: a) Board Certification or qualified for certification by the American Board of Vascular Surgery; b) Completion
HAEMODIALYSIS. Types of vascular access used for first haemodialysis 2012 to June 2016
SECTION H VASCULAR ACCESS FOR HAEMODIALYSIS Details of vascular access used for haemodialysis for all hospital and home haemodialysis patients were collected during the SRR census week in May 2016. The
Society for Vascular Surgery Vascular Annual Meeting Boston, MA June 20-23, 2018 SCHEDULE OF EVENTS. (as of 3/05/18)
Society for Vascular Surgery Vascular Annual Meeting Boston, MA June 20-23, 2018 SCHEDULE OF EVENTS (as of 3/05/18) Wednesday, June 20, 2018 6:00-6:30 pm 7:00-10:00 am Postgraduate Courses P1: Aortoiliac
Medical Director/Surgeon as Partners WebEx February 11, 2010
Medical Director/Surgeon as Partners WebEx February 11, 2010 Over 400,000 patients are treated yearly for ESRD in the USA; 60% of these patients receive some form of hemodialysis Despite major advances
Pros and Cons in Vascular Surgery
LSVS LEBANESE SOCIETY FOR VASCULAR SURGERY Pros and Cons in Vascular Surgery 2 nd Edition NOVEMBER 17, 2018 Le Bristol Hotel Beirut - Lebanon Welcome Letter Dear Colleagues, It is our pleasure to welcome
The following are the objectives to be successfully completed by the IR fellow at the completion of training.
GOALS and OBJECTIVES The following are the objectives to be successfully completed by the IR fellow at the completion of training. I. Patient Care Fellows must be able to provide patient care that is compassionate,
Bare Metal Stents vs Stent Grafts
Bare Metal Stents vs Stent Grafts ASDIN 12th Annual Scientific Meeting Phoenix, AZ, February 20, 2016 Dirk Hentschel, MD Director, Interventional Nephrology Brigham and Women s Hospital Disclosure Consultant:
Mayo Clinic Course on Shoulder Tendon Transfers & Complex Rotator Cuff Repair Program Schedule
Mayo Clinic Course on Shoulder Tendon Transfers & Complex Rotator Cuff Repair Program Schedule Thursday, April 27, 2017 6:30 a.m. Registration and Continental Breakfast 6:50 a.m. Welcome and Announcements
IN.PACT AV Access IDE Study Full Baseline Data. Robert Lookstein, MD MHCDL New York, NY On Behalf of the IN.PACT AV ACCESS Investigators
IN.PACT AV Access IDE Study Full Baseline Data Robert Lookstein, MD MHCDL New York, NY On Behalf of the IN.PACT AV ACCESS Investigators Disclosures Speaker name: Robert Lookstein, MD... I have the following
JVA ISSN Primary and secondary patencies of transposed femoral vein fistulas are significantly greater than with the HeRO graft
JVA ISSN 1129-7298 J Vasc Access 2017; 00 (00): 000-000 DOI: 10.5301/jva.5000697 ORIGINAL RESEARCH ARTICLE Primary and secondary patencies of transposed femoral vein fistulas are significantly greater
Postoperative AV Fistula Evaluation. Postoperative examination protocol. Postoperative AVF Protocol. Hemodialysis Access Surveillance
Hemodialysis Access Surveillance Postoperative AV Fistula Evaluation Failure of maturation Stenosis Perigraft mass/fluid collection Joseph L. Mills, Sr., M.D. Professor of Surgery Chief, Division of Vascular
CATHETER REDUCTION. Angelo N. Makris, M.D. Medical Director Chicago Access Care
CATHETER REDUCTION Angelo N. Makris, M.D. Medical Director Chicago Access Care Objectives Discuss tools/techniques proven to improve AVF rates & decrease catheter rates Implement a change process in your
13 th VAS Course, November 2 4, 2016 in Bern Final Program 8. Berner Fisteltag, November 2, 2016 in Bern
13 th VAS Course, November 2 4, 2016 in Bern Final Program 8. Berner Fisteltag, November 2, 2016 in Bern SPONSORS NOVEMBER 2, 2016: Combined Plenary Session VAS Course & Berner Fisteltag NOVEMBER 3 + 4,
Interventions for AV-Shunt stenosis: What works best PTA, Stent or DCB?
Interventions for AV-Shunt stenosis: What works best PTA, Stent or DCB? Martin Forlee Vascular Surgeon Cape Town Disclosure Speaker name: Martin Forlee I have the following potential conflicts of interest
COVERA Vascular Covered Stents in the Management of Dysfunctional AV Access
COVERA Vascular Covered Stents in the Management of Dysfunctional AV Access Bart L. Dolmatch, M.D., FSIR Palo Alto Medical Foundation Mountain View, CA USA This presentation is being made on behalf of
Society for Vascular Surgery Vascular Annual Meeting San Diego, CA May 31 - June 3, 2017 SCHEDULE OF EVENTS. (as of 2/ 23/ 17)
Society for Vascular Surgery Vascular Annual Meeting San Diego, CA May 31 - June 3, 2017 SCHEDULE OF EVENTS (as of 2/ 23/ 17) Tuesday, May 30, 2017 12:00-6:30 pm VQI Annual Meeting Wednesday, May 31, 2017
Society for Vascular Surgery Vascular Annual Meeting Boston, MA June 20-23, 2018 SCHEDULE OF EVENTS. (as of 3/26/18)
Society for Vascular Surgery Vascular Annual Meeting Boston, MA June 20-23, 2018 SCHEDULE OF EVENTS (as of 3/26/18) Wednesday, June 20, 2018 6:00-6:30 pm 7:00-10:00 am Postgraduate Courses P1: Aortoiliac
Current treatment status and medical costs for hemodialysis vascular access based on analysis of the Korean Health Insurance Database
ORIGINAL ARTICLE Korean J Intern Med 218;33:116-1168 https://doi.org/1.394/kjim.218.17 Current treatment status and medical costs for hemodialysis vascular access based on analysis of the Korean Health
End Stage Renal Disease (ESRD) Network Learning and Action Network (LAN) Series: Bloodstream Infection (BSI) Quality Improvement Activity
End Stage Renal Disease (ESRD) Network Learning and Action Network (LAN) Series: Bloodstream Infection (BSI) Quality Improvement Activity October 2, 2018 Note: Computer speakers or headphones are necessary
Outcome of a comprehensive follow-up program to enhance maturation of autogenous arteriovenous hemodialysis access
From the Society for Clinical Vascular Surgery Outcome of a comprehensive follow-up program to enhance maturation of autogenous arteriovenous hemodialysis access Robert B. McLafferty, MD, Raymond W. Pryor
Joint Banff/CST Program Committee Co-chairs: Dr. Alexandre Loupy and Dr. Prosanto Chaudhury. Joint Banff/CST Finance Committee
2015 Banff/CST Meeting Organizing Corporation ( 2015 MOC ) Co-Directors: Dr. John Gill, Dr. Michael Mengel Members: Anthony Jevnikar, David Rush, Denis Glotz, Kim Solez, Marcelo Cantarovich, Mark Haas,
Technical and Clinical Barriers to Implementing an Optimal Case Mix of Vascular Access
Technical and Clinical Barriers to Implementing an Optimal Case Mix of Vascular Access Louise Moist Associate Professor Lead Vascular Access Ontario Renal Network Schulich School of Medicine University
The SplitWire Percutaneous Transluminal Angioplasty Scoring Device. Instructions for Use
The SplitWire Percutaneous Transluminal Angioplasty Scoring Device Instructions for Use Contents Contains one (1) SplitWire device. Sterile. Sterilized with ethylene oxide gas. Radiopaque. For single use
Guidelines for Arteriovenous Access Intervention, Management and Abandonment, and for Removal of Pre- Study Dialysis Catheter
Guidelines for Arteriovenous Access Intervention, Management and Abandonment, and for Removal of Pre- Study Dialysis Catheter The guidelines for arteriovenous access intervention, management and abandonment,
Clinical Study Endovascular Stent Placement for Hemodialysis Arteriovenous Access Stenosis
International Vascular Medicine Volume 215, Article ID 97122, 7 pages http://dx.doi.org/1.1155/215/97122 Clinical Study Endovascular Stent Placement for Hemodialysis Arteriovenous Access Stenosis Brendon
Dr. Murty Mantha MD FRACP Cairns Base Hospital Cairns. DNT 2011 Hunter Valley
Dr. Murty Mantha MD FRACP Cairns Base Hospital Cairns DNT 2011 Hunter Valley Approximately 45% of AVF are functional without intervention after creation The procedure rate is 1.45-3.3 procedures/avf
Arteriovenous Graft Modeling and Hemodynamic Interpretation
Open Journal of Fluid Dynamics, 2012, 2, 324-330 http://dx.doi.org/10.4236/ojfd.2012.24a040 Published Online December 2012 (http://www.scirp.org/journal/ojfd) Arteriovenous Graft Modeling and Hemodynamic
PATIENTS WITH SIX CANNULATION SITES FOR HEMODIALYSIS CORRELATED WITH DECREASED OCCURRENCE OF AV SHUNT THROMBOSIS IN TAIPEI HOSPITAL
PATIENTS WITH SIX CANNULATION SITES FOR HEMODIALYSIS CORRELATED WITH DECREASED OCCURRENCE OF AV SHUNT THROMBOSIS IN TAIPEI HOSPITAL MICHAEL LEE, OMS II, 1 ATHENA LIN, PH.D., 1 YIN-CHENG CHEN, M.D. 2 1
AVF Prevalence. Local elastase to aid fistula maturation. I have nothing to disclose
Local elastase to aid fistula maturation Warren Gasper MD UCSF Vascular Surgery Fellow 2013 UCSF Vascular Symposium I have nothing to disclose AVF Prevalence 60.6% (April 2012) Fistula First Initiative
Hemodialysis Fistula Maturation Consortium
Hemodialysis Fistula Maturation Consortium Rationale for Fistula Maturation Study Dialysis Access Consortium AVF study 60% of new AVFs were unusable for dialysis at 4-5 months post surgery No predictors
Victoria Chapman BS, RN, HP (ASCP)
Victoria Chapman BS, RN, HP (ASCP) Considerations: Age Sex Body Composition Hydration Status Chemotherapy Use Access History Considerations: Immunosuppression Use Chemotherapy Frequency of plasma exchanges
Mayo Clinic Disorders of the Wrist
Mayo Clinic Disorders of the Wrist Thursday, May 16, 2019 Pre-Conference Laboratory Workshop Anatomy of the Wrist 6:45 a.m. Pre-Conference Registration and Breakfast 7:00 a.m. Welcome and Introduction
Conference Program. STS/EACTS Latin America Cardiovascular Surgery Conference. November 15-17, 2018 Cartagena, Colombia
Conference Program STS/EACTS Latin America Cardiovascular Surgery Conference November 15-17, 2018 Cartagena, Colombia www.cardiovascularsurgeryconference.org info@cardiovascularsurgeryconference.org STS/EACTS
on Skills Training Workshop in Vascular Access: A Multidisciplinary Approach
VII HANDS-ON HANDS SKILLS TRAINING WORKSHOP IN VASCULAR ACCESS: VI Hands-on on Skills Training Workshop in Vascular Access: A Multidisciplinary Approach May 8-10, 2017 Sabadell, Barcelona With Support
Balloon angioplasty for arteriovenous graft stenosis Anain P, Shenoy S, O'Brien M, Harris L M, Dryjski M
Balloon angioplasty for arteriovenous graft stenosis Anain P, Shenoy S, O'Brien M, Harris L M, Dryjski M Record Status This is a critical abstract of an economic evaluation that meets the criteria for
ENDOVASCULAR TREATMENT OF MALFUNCTIONING HAEMODIALYSIS GRAFTS/FISTULAS. Dr R Uberoi Interventional Radiologist John Radcliffe hospital Oxford.
ENDOVASCULAR TREATMENT OF MALFUNCTIONING HAEMODIALYSIS GRAFTS/FISTULAS Dr R Uberoi Interventional Radiologist John Radcliffe hospital Oxford. Stenosis Stenosis Native fistula/grafts. Radio-cephalic 55-75%
Decreased Incidence of Clotted AV Access in Hemodialysis Patients after the Implementation of Follow up Program
Global Journal of Health Science; Vol. 8, No. 10; 2016 ISSN 1916-9736 E-ISSN 1916-9744 Published by Canadian Center of Science and Education Decreased Incidence of Clotted AV Access in Hemodialysis Patients
ICCA Carotid Angioplasty and Other Cerebrovascular Interventions. Preliminary Scientific Program as of September 2011
ICCA 2011 Carotid Angioplasty and Other Cerebrovascular Interventions October 21 22, 2011 Wiesbaden Germany With Live Cases Preliminary Scientific Program as of September 2011 www.iccaonline.org Scientific
BC VASCULAR DAY PRELIMINARY PROGRAM. November 3, :30am 4:00pm
7:30am 4:00pm University of British Columbia 6163 University Boulevard Vancouver, B.C. V6T 1Z1 PRELIMINARY PROGRAM The Most Comprehensive One-Day Vascular Symposium in British Columbia For registration:
Friday, May 17, 2019 General Session Controversies in Wrist Surgery 6:45 a.m. Registration and Breakfast Leighton Auditorium Siebens Building 7:25
Mayo Clinic Controversies in Wrist Surgery May 16 19, 2019 Rochester, MN Thursday, May 16, 2019 Pre-Conference Laboratory Workshop Anatomy of the Wrist (Optional add-on) 6:45 a.m. Pre-Conference Registration
Sid Bhende MD Sentara Vascular Specialists April 28 th Dialysis Access Review: Understanding the Access Options our Patients Face
Sid Bhende MD Sentara Vascular Specialists April 28 th 2018 Dialysis Access Review: Understanding the Access Options our Patients Face Disclosures Dialysis Background Why is it important? Outline National
FIRST ANNUAL ORLANDO COLORECTAL CONGRESS LIVE! November 8-10, 2017
FIRST ANNUAL ORLANDO COLORECTAL CONGRESS LIVE! November 8-10, 2017 Florida Hospital Nicholson Center 404 Celebration Place Celebration, FL 34747 Featuring: Presented by: Center for Colon & Rectal Surgery
Konstantinos Katsanos, MSc, MD, PhD, EBIR
Konstantinos Katsanos, MSc, MD, PhD, EBIR Interventional Radiologist Patras University Hospital, Rion, Greece & Guy s and St. Thomas Hospitals, London, UK Honoraria from MEDTRONIC, BOSTON SCI Research
Selection of Permanent Hemodialysis Vascular Access
Selection of Permanent Hemodialysis Vascular Access TABLE OF CONTENTS 1.0 Scope...1 2.0 Recommendations & Rationale... 2 3.0 References... 3 4.0 Sponsors... 9 5.0 Effective Date... 10 Appendix 1: Key Elements
Distal Hypoperfusion Ischemic Syndrome (DHIS)
Pathophysiology Traditional View ( Steal Syndrome ) Distal Hypoperfusion Ischemic Syndrome (DHIS) Steven Wu, MD Director of Interventional Nephrology Massachusetts General Hospital Harvard Medical School
PREVENTION AND TREATMENT OF ANEURYSMS OF AUTOGENOUS DIALYSIS ACCESSES STEPHEN L. HILL, M.D.,F.A.C.S
PREVENTION AND TREATMENT OF ANEURYSMS OF AUTOGENOUS DIALYSIS ACCESSES STEPHEN L. HILL, M.D.,F.A.C.S THE INCREASE IN THE CONSTRUCTION OF AUTOGENOUS FISTULAE OVER THE PAST TEN YEARS HAS BROUGHT WITH IT 1.
Vascular Surgery Rotation Objectives for Junior Residents (PGY-1 and 2)
Vascular Surgery Rotation Objectives for Junior Residents (PGY-1 and 2) Definition Vascular surgery is the specialty concerned with the diagnosis and management of congenital and acquired diseases of the
Cephalic Arch Stenosis: A unique entity
Cephalic Arch Stenosis: A unique entity Arif Asif, M.D. Professor of Medicine Director, Interventional Nephrology University of Miami, Miami, FL PUMP Kian K, Asif A: Semin Dial 2008 Prevalence of CAS 39%
Vascular Surgery Fellowship Curriculum Goals and Objectives
Vascular Surgery Fellowship Curriculum Goals and Objectives Educational Goals and Philosophy.. Page 2 Program Overview. Page 2 Curriculum Overview.. Page 3 Goals and Objectives for Competencies Page 3
Interventional Treatment for Complete Occlusion of Arteriovenous Shunt: Our Experience in 39 cases
Chin J Radiol 2003; 28: 137-142 137 Interventional Treatment for Complete Occlusion of Arteriovenous Shunt: Our Experience in 39 cases SHE-MENG CHENG SUK-PING NG FEI-SHIH YANG SHIN-LIN SHIH Department
Mayo Clinic Disorders of the Wrist
Mayo Clinic Disorders of the Wrist Thursday, May 19, 2016 Pre-Conference Laboratory Workshop Anatomy of the Wrist & Wrist Arthroscopy 6:30 a.m. Registration and Breakfast 7:30 a.m. Welcome and Introduction
We are IntechOpen, the world s leading publisher of Open Access books Built by scientists, for scientists. International authors and editors
We are IntechOpen, the world s leading publisher of Open Access books Built by scientists, for scientists 4,000 116,000 120M Open access books available International authors and editors Downloads Our
Joint Congress PAFCIC Complex PCI meeting
Joint Congress PAFCIC Complex PCI meeting October 18-20, 2018, Nairobi, KENYA The Program : - Interactive sessions - Practical workshops - Key note lectures - Live transmissions - Poster and oral presentations
Angioplasty remains the most common method
When AVF Angioplasty Fails Defining procedural success and overcoming common problems. By Thomas M. Vesely, MD Angioplasty remains the most common method of treating obstructive vascular stenoses associated